Nature Communications (Jul 2022)

A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection

  • Iris N. Pardieck,
  • Tetje C. van der Sluis,
  • Esmé T. I. van der Gracht,
  • Dominique M. B. Veerkamp,
  • Felix M. Behr,
  • Suzanne van Duikeren,
  • Guillaume Beyrend,
  • Jasper Rip,
  • Reza Nadafi,
  • Elham Beyranvand Nejad,
  • Nils Mülling,
  • Dena J. Brasem,
  • Marcel G. M. Camps,
  • Sebenzile K. Myeni,
  • Peter J. Bredenbeek,
  • Marjolein Kikkert,
  • Yeonsu Kim,
  • Luka Cicin-Sain,
  • Tamim Abdelaal,
  • Klaas P. J. M. van Gisbergen,
  • Kees L. M. C. Franken,
  • Jan Wouter Drijfhout,
  • Cornelis J. M. Melief,
  • Gerben C. M. Zondag,
  • Ferry Ossendorp,
  • Ramon Arens

DOI
https://doi.org/10.1038/s41467-022-31721-6
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 11

Abstract

Read online

Vaccination regimens and the number of doses required for optimal immunity and protection are critical factors in the translation of vaccines. Here the authors show administration of a three dose protocol of a single T cell epitope to the SARS-CoV-2 spike protein induces a robust CD8+ T cell response and confers protection in a lethal murine challenge model of infection.